Efficacy of Acacia nilotica Linn. Pod’s Sitz Bath plus Vaginal Pessary in Syndromic Management of Abnormal Vaginal Discharge: A Randomized Controlled Trial
Table 2
Primary Outcome: VAS scoring of symptoms and the Modified McCormack Pain Scale in the Acacia and the control group.
Primary outcome
Acacia group (n = 33)
Placebo group (n = 33)
value
VAS for LAP and LBA
Day 0
4.66 ± 1.68
5.18 ± 1.26
0.26
Days 11–14
1.36 ± 1.72
5.06 ± 1.27
<0.0001
Day 45
0.63 ± 1.02a
4.90 ± 1.33b
<0.0001
VAS for abnormal vaginal discharge
Day 0
6.39 ± 0.70
6.12 ± 0.59
0.39
Days 11–14
1.51 ± 2.04
6 ± 0.61
<0.0001
Day 45
0.60 ± 1.19a
6 ± 0.61b
<0.0001
VAS for dyspareunia
Day 0
1.54 ± 2.32
1.75 ± 2.34
0.83
Days 11–14
0.15 ± 0.44
1.72 ± 2.34
0.02
Day 45
0.03 ± 0.17a
1.60 ± 2.20b
0.007
VAS for dysuria
Day 0
1.69 ± 2.43
1.84 ± 2.43
0.74
Days 11–14
1.69 ± 2.43
1.81 ± 2.39
0.04
Day 45
0.09 ± 0.29a
1.66 ± 2.21b
0.008
VAS for burning micturition
Day 0
3.48 ± 2.48
3 ± 2.44
0.38
Days 11–14
0.75 ± 1.03
2.84 ± 2.34
0.0007
Day 45
0.33 ± 0.64a
2.69 ± 2.24b
0.0001
VAS for vulvar irritation
Day 0
3.18 ± 2.55
3 ± 2.72
0.94
Days 11–14
0.87 ± 1.34
2.87 ± 2.64
0.003
Day 45
0.18 ± 0.46a
2.84 ± 2.60b
<0.0001
VAS for vulvar itching
Day 0
4.63 ± 2.14
3.90 ± 2.45
0.18
Days 11–14
1.42 ± 1.73
3.78 ± 2.23
<0.0001
Day 45
0.39 ± 0.65a
3.63 ± 2.35b
<0.0001
Modified McCormack Pain Scale (McPS) for abdominal tenderness
Day 0
2.36 ± 1.43
2.36 ± 1.43
0.43
Days 11–14
1.06 ± 1.36
1.96 ± 1.28
0.01
Day 45
0.33 ± 0.76a
1.93 ± 1.24b
<0.0001
Data presented were as follows: mean ± SD; a considered extremely significant on Day 11 and Day 30 from Day 0 in the Acacia group. b considered not significant on days 11–14 and Day 45 from Day 0 in the placebo group; tests used were as follows: Wilcoxon matched paired test VAS : visual analogue scale; LAP : lower abdominal pain; LBA : low backache.